Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Goldsmith

Mark Goldsmith, Victoria AU

Patent application numberDescriptionPublished
20090169691Methods and Compositions for Fining Beverages - The present invention provides a finings formulation comprising pectin and methods of using pectin in a fining process to produce fined beverages, particularly beers.07-02-2009

Michael Goldsmith, Kitchener CA

Patent application numberDescriptionPublished
20080294923SYSTEM AND METHOD FOR INTERFACING AN ELECTRONIC DEVICE WITH A HOST SYSTEM - The invention relates to a system and method for controlling interfacing parameters for a device when connected to a host is provided. The method comprises: monitoring for an initial connection by the device to the host; then, while the device is establishing the connection with the host, utilizing a communication bus controller contained in a microprocessor in the device to process communications with the host at a first data transmission rate; and after a predetermined condition, re-establishing the connection with the host using a second bus controller in the device that processes the communications at a second transmission rate that is higher the first data transmission rate.11-27-2008
20100057973SYSTEM AND METHOD FOR INTERFACING AN ELECTRONIC DEVICE WITH A HOST SYSTEM - The disclosure describes a system and method for controlling interfacing parameters for a device when connected to a host. In the system and method, the communications interface is configurable to be in operable connection to a host using a microprocessor in the device having a first bus controller and a second bus controller, the second bus controller external to the microprocessor. The method comprises: establishing an initial connection by the device; conducting negotiations by the device to set a first data transmission rate for the device for the initial connection utilizing a communication bus controller contained in the microprocessor; and after detecting completion of enumeration of the device, re-establishing the connection by the device using the second bus controller in the device that processes the communications at a second transmission rate that is higher than the first data transmission rate.03-04-2010

Michael Andrew Goldsmith, Kitchener CA

Patent application numberDescriptionPublished
20100185786SYSTEMS AND METHODS FOR MAINTAINING DATA INTEGRITY OF REMOVABLE MEDIA OF AN ELECTRONIC DEVICE - The described embodiments relate generally to methods, systems and devices for maintaining data integrity of a removable media card of a handheld electronic device, particularly when such media card is removed from such device.07-22-2010

Paul Goldsmith, Basel CH

Patent application numberDescriptionPublished
20090247567BENZOPYRAN AND BENZOXEPIN PI3K INHIBITOR COMPOUNDS AND METHODS OF USE - Benzopyran and benzoxepin compounds of Formulas I and II, and including stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, are useful for inhibiting lipid kinases including p110 alpha and other isoforms of PI3K, and for treating disorders such as cancer mediated by lipid kinases. Methods of using compounds of Formulas I and II for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.10-01-2009
20110053935FUSED PYRIDINES ACTIVE AS INHIBITORS OF C-MET - Fused pyridines of formula (I) and the pharmaceutically acceptable salts thereof have activity as inhibitors of c-Met and may thus be used to treat various diseases and disorders including cancer. Processes for synthesizing the compounds are also described.03-03-2011
20110130363BENZOPYRAN AND BENZOXEPIN PI3K INHIBITOR COMPOUNDS AND METHODS OF USE - Benzopyran and benzoxepin compounds of Formulas I and II, and including stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, are useful for inhibiting lipid kinases including p110 alpha and other isoforms of PI3K, and for treating disorders such as cancer mediated by lipid kinases. Methods of using compounds of Formulas I and II for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.06-02-2011

Yona Goldsmith, Victoria AU

Patent application numberDescriptionPublished
20080254023Treating Gliosis, Glial Scarring, Inflammation or Inhibition of Axonal Growth in the Nervous System by Modulating Eph Receptor - The present invention relates to a method of treating disorders of the nervous system and more particularly disorders associated with a gliotic response and/or an inflammatory response within the central nervous system and to therapeutic agents useful for same. More particularly, the present invention involves a method of preventing or reducing the amount of Eph receptor-mediated gliosis and/or glial scarring and/or inflammation and/or Eph receptor-mediated inhibition of axonal growth which occurs during and/or after disease or injury to the nervous system. The present invention also facilitates the identification of therapeutic agents which modulate Eph receptor-mediated signaling. The method and therapeutic agents of the present invention are useful for treating a range of nervous system diseases, conditions and injuries including, inter alia, paralysis induced by physiological-, pathological- or trauma-induced injury to the brain or spinal cord.10-16-2008